Global Collagen and Gelatin Market for Regenerative Medicine Market - $700+ Million Opportunity 2014-2017 Analysis and Industry Forecasts 2017-2022

Dublin, Jan. 04, 2018 -- The "Collagen and Gelatin Market for Regenerative Medicine - Global Opportunity Analysis and Industry Forecast (2017-2022)" report has been added to Research and Markets' offering.

Global collagen and gelatin market for regenerative medicine is expected to reach USD 709.9 million by 2022, at a CAGR of 8.5% during the forecast period of 2017 to 2022.

Collagen and gelatin are found throughout the human body, but mainly in the skin and bones. After certain age, the natural production of collagen in the body decreases. The lack of collagen gives rise to chronic diseases such as osteoporosis i.e. bone and joint discomfort, chronic wounds, cardiovascular diseases, and other neurodegenerative disorders. These chronic diseases result in the organ and tissue loss which leads the development of therapies that can regenerate tissues.

Regenerative medicine, an interdisciplinary field that applies engineering and life science principles to promote regeneration potentially restores diseased and injured tissues and whole organs. Since the inception of the field several decades ago, a number of regenerative medicine therapies, including those designed for wound healing, heart diseases, and orthopedics applications have received an approval from Food and Drug Administration (FDA). Specifically, there are various developments in fabricating sophisticated grafts and tissue mimics and technologies for integrating grafts. The use of collagen and gelatin-based biomaterials in the field of regenerative medicine applications has been intensively growing over the past decades. It is now widely used in both research environments and medical applications as they possess a major advantage of being biodegradable, biocompatible, easily available, low immunogenicity, and highly versatile, boosting the growth of collagen and gelatin market for regenerative medicine.

Succeeding an extensive secondary and primary research on collagen and gelatin based regenerative medicine and an in-depth analysis of the market scenario, the report carries out an impact analysis of the key industry drivers, restraints, and opportunities listed in the market dynamics segment.

Rising prevalence of chronic diseases, rapid growth in aging population, and increasing funding for R&D of regenerative medicines are driving the growth of global collagen and gelatin market for regenerative medicine. Moreover, emerging economies such as Asia-Pacific and Latin America provides significant opportunities in this market, primarily due to increasing life expectancy which gives rise to chronic diseases, and increase in the meat production. However, growing use of alternate biomaterials inhibits the growth of this market to some extent.

The report analyses the global collagen & gelatin market for regenerative medicine by type (collagen and gelatine), source (bovine, porcine, marine, and others), application (orthopaedics, wound care, cardiovascular, and others), and geography.

Scope of the report

Market by Type

• Collagen
• Gelatin

Market by Source

• Bovine
• Porcine
• Marine
• Others

Market by Application

• Orthopedic
• Wound Care
• Cardiovascular
• Others

Key Topics Covered:

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Insights

5. Collagen and Gelatin Market for Regenerative Medicine, By Type

6. Global Collagen & Gelatin Market for Regenerative Medicine, By Source

7. Global Collagen and Gelatin Market for Regenerative Medicine, By Application

8. Collagen & Gelatin Market for Regenerative Medicine, By Geography

9. Competitive Landscape

10. Company Profiles (Business Overview, Financials, Product Portfolio, Recent Developments)

• Advanced BioMatrix (U.S.)
• Collagen Solutions Plc (U.S.)
• EnColl Corporation (U.S.)
• GELITA AG (Germany)
• Jellagen Pty Ltd (U.K.)
• Nitta Gelatin Inc. (Japan)
• NuCollagen LLC (U.S.)
• Royal DSM (Netherlands)
• Symatese (France)
• Tessenderlo Group (Belgium)
• Vornia Biomaterials (Ireland)
• XIAMEN HYFINE GELATIN CO. LTD

For more information about this report visit https://www.researchandmarkets.com/research/kkgwj3/global_collagen?w=12

CONTACT: Research and Markets
         Laura Wood, Senior Manager
         [email protected]
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         Related Topics: Biopharmaceuticals